ZILLION GROUP, INC. – Trademark Portfolio
Entity Type: 03
ZILLION GROUP, INC. has 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include ZILLION. The portfolio includes 1 registered trademark. Filings span 4 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 44 (Medical Services). This trademark owner is based in NORWALK, CT.
501 MERRITT 7
NORWALK, CT 06851
Showing of trademarks Trademarks
Trademark Classifications
ZILLION GROUP, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ZILLION GROUP, INC. have?
ZILLION GROUP, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 3 cancelled.
What trademark classes does ZILLION GROUP, INC. file in?
ZILLION GROUP, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ZILLION GROUP, INC.'s most well-known trademarks?
ZILLION GROUP, INC.'s registered trademark portfolio includes well-known marks such as ZILLION. These are among 1 currently registered trademark in the portfolio.
What is ZILLION GROUP, INC.'s trademark registration success rate?
ZILLION GROUP, INC. has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.